Fighting Cancer with
A Single Draw of Blood
Lucence develops cutting-edge genomic tests
for cancer detection and treatment selection.
UPDATE: The race against time for a COVID-19 vaccine continues.
How can mass-testing and diagnostics technology be improved to alleviate this crisis now?
Register for our Aug 5 webinar here: https://bit.ly/2XjwSIo.
We have developed a COVID-19 viral saliva sample collection kit, called SAFER™ Sample.
A great test is nothing without a good sample.
SAFER™ Sample is a sampling kit that allows swab and saliva samples to be collected for COVID-19 PCR-based testing*.
Next-generation cancer care today
An emerging medical discipline, Genomic Medicine uses your genomic information for diagnostic or therapeutic decision-making, enabling more effective treatments and better health outcomes.
Every cancer is different.
So is our approach.
No two people are the same, and neither are their cancers. This means that even if two people are diagnosed with the same cancer, they may respond differently to the same treatment. Therefore, the first step to fighting cancer begins with uncovering the mutations that drive each person’s cancer.
Genomic medicine is a new medical approach which customizes healthcare to each person’s unique genetic make-up. Our genome-based diagnostic tests allow doctors to see the clearer picture, and make more informed decisions for better cancer care.
The future of fighting cancer.
Detects cancer before symptoms show and checks for genetic risk of developing cancer. Early detection will enable earlier treatment and improve survival rates.
Detects mutations in the tumor that will respond well to specific targeted drugs. This helps physicians to tailor drug treatments to the individual patient.